Help us: Donate
Follow us on:
×

Lewis Gruber

Lewis Gruber

SIWA Therapeutics

Lewis S. Gruber is CEO, Chief Scientific Officer and Co-Founder of SIWA Therapeutics. He is also the named inventor on all of SIWA Therapeutics’ portfolio of more than 60 global patents.Prior to founding SIWA, Gruber served as interim CEO of ZelleRX, an early stage biotechnology company with a natural killer cell therapy that destroys cancer cells. From 2000 to 2006, Gruber was CEO and Co-Founder of Arryx, Inc., a Chicago biotechnology company that brought to market a breakthrough research tool that uses lasers to allow researchers to simultaneously manipulate hundreds of microscopic objects in three dimensions. Under Gruber’s leadership, Arryx was recognized as a World Economic Forum Technology Pioneer as well as a Red Herring Top 100 Innovator. Before co-founding Arryx, Gruber was CEO of Hyseq, Inc., a biotechnology company with a proprietary genomic platform that facilitated gene discovery and led to the development of numerous therapeutic drugs. While CEO of Hyseq, Gruber completed the largest initial public offering of a biotechnology company in 1997. He also led the negotiation of commercial partnerships that generated more than $100 million.Previously, Gruber was a member of the Illinois Biotechnology Industry Organization (iBio) Board of Directors and served on the Advisory Board of Northwestern University’s Kellogg School of Management Center for Biotechnology. Currently, Gruber serves on the Board of Trustees for the Field Museum of Natural History and is a member of the Advisory Council of the Oriental Institute at the University of Chicago. Before becoming a biotech entrepreneur, Gruber was a patent attorney in Chicago and specialized in the biotechnology, life sciences, pharmaceuticals, genomics and medical device industries. Gruber earned his J.D. from Arizona State University in 1981, an M.S. in Biology from the University of Arizona in 1978 and a Bachelor of Science in Sociology from the University of Arizona in 1973.